• Login
    View Item 
    •   Home
    • Theses and Dissertations
    • Theses and Dissertations
    • View Item
    •   Home
    • Theses and Dissertations
    • Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of Scholarly CommonsCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    About

    AboutCreative CommonsAugusta University LibrariesUSG Copyright Policy

    Statistics

    Display statistics

    The Effects of Endocrine Dysfunction on the Cerebrovasculature and Stroke

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Osmond, Jessica Martin
    Issue Date
    2010-02
    URI
    http://hdl.handle.net/10675.2/319901
    
    Metadata
    Show full item record
    Abstract
    Stroke is the third leading cause of death in the United States and the leading cause of disability among adults.1 According to the American Heart Association Heart Disease and Stroke 2008 Update,1 there is, on average, 1 stroke every 40 seconds in the United States, and every 3-4 minutes someone dies of a stroke. Furthermore, stroke is a major financial burden on the healthcare system, and its prevalence will only continue to increase as the prevalence of its risk factors continues to increase. These risk factors include but are not limited to hypertension, atherosclerosis, diabetes, smoking, and obesity. Currently, therapy for ischemic stroke is very limited. The only approach for acute treatment of ischemic stroke approved by the Food and Drug Administration is clot lysis with tissue plasminogen activator (tPA), based on findings from the National Institute of Neurological Disorders and Stroke recombinant tPA Stroke Study Group demonstrating improvement in clinical outcome with tPA therapy compared to placebo-control patients.2 Patients receiving tPA therapy showed improvements in neurological outcome 3 months after stroke compared to patients receiving placebo. However, the window of treatment for tPA is very small and only a small percentage (<10%) of eligible 2 patients receive therapy. Although efforts to develop safe and effective treatment options for stroke patients continue, a gap remains between promising findings from the bench and positive results in clinical trials. In light of this, it is especially important that research is also focused on gaining better understanding of mechanisms that lead to increased stroke occurrence and increased stroke damage in order to make progress in diminishing the occurrence of stroke.
    Affiliation
    Department of Physiology
    Collections
    Theses and Dissertations
    Department of Physiology Theses and Dissertations

    entitlement

     
    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.